Abstract Proceedings of ICIRESM – 2019
Full conference PDF is available to the subscribed user. Use your subscription login to access,
MONOCLINIC BISMUTH VANADATE NANOPARTICLES SUPPORTED BY REDUCED GRAPHENE OXIDE WERE USED AS AN ELECTROCATALYST TO DETECT DOPAMINE IN HUMAN URINE SAMPLES.
According to a WHO report, neurological illnesses claim the lives of 6.8 million people each year. Dopamine detection in bio fluids is essential in the medical field for disease diagnosis and early disease detection. BiVO4 and various concentrations of rGO-loaded BiVO4 were created in this study using a hydrothermal technique and a reflux method. BiVO4 and rGO/BiVO4 nanocomposite production is confirmed by the various analyses. Glassy carbon electrode (GCE), BiVO4/GCE, 5rGO/BiVO4/GCE, 15rGO/BiVO4/GCE, and 30rGO/BiVO4/GCE nanocomposite have electrochemical active surface areas of 0.0747, 0.0585, 0.06696, 0.0714, and 0.0774 cm2, respectively. The 30rGO/BiVO4 nanocomposite demonstrated a significant electrocatalytic current for dopamine oxidation. The 30rGO/BiVO4 nanocomposite showed a greater catalytic current in pH 3 phosphate buffer solutions (PBS) compared to pH (4-7) and was selected as the ideal pH.
WHO report, lives of 6.8 million people, medical field, BiVO4, hydrothermal technique, nanocomposite, electrochemical active surface.
30/08/2019
255
19246
IMPORTANT DAYS
Paper Submission Last Date
October 20th, 2024
Notification of Acceptance
November 7th, 2024
Camera Ready Paper Submission & Author's Registration
November 1st, 2024
Date of Conference
November 15th, 2024
Publication
January 30th, 2025